BioCentury
ARTICLE | Clinical News

Mylotarg gemtuzumab zogamicin regulatory update

March 20, 2000 8:00 AM UTC

The FDA's Oncologic Drugs Advisory Committee voted 11-2 to recommend accelerated approval of the partners' NDA for Mylotarg, a humanized antibody against CD33 linked to the calicheamicin cytotoxin, t...